Stocks/EVGN

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

EVGN

↓ PDF (Pro)
Evogene Ltd Ordinary Shares
HealthcareBiotechnologyIsraelNASDAQ
$0.80
+3.79%today
MKT CAP
$10M
-3.6% · 1Y
Earnings History
+24.8%
+20.6%
-13.4%
-137.5%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$0.80
Low
$2.25
Analyst Mean
$2.25
High
$2.25
1 analystNone
Full Financials
Trailing P/E-
Forward P/E-1.0x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+0.6%
5y Revenue CAGR+32.0%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership1.0%
Institutional Ownership2.3%
Short % of Float1.41%
Days to Cover1.4d
1 Week-3.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
SilverArc Capital Management, LLCinstitution0.61%$0.00B-0.47%2024-03-31
Morgan Stanleyinstitution0.06%$0.00B+50.73%2024-03-31
BNP Paribas Financial Marketsinstitution0.02%$0.00B+30.76%2024-03-31
LPL Financial LLCinstitution0.01%$0.00B+0.00%2024-03-31
JP Morgan Chase & Companyinstitution0.01%$0.00B-38.95%2024-03-31
UBS Group AGinstitution0.01%$0.00B+11.59%2024-03-31
Geode Capital Management, LLCinstitution0.01%$0.00B+0.00%2024-03-31
Renaissance Technologies, LLCinstitution0.01%$0.00B+0.00%2024-03-31
Citadel Advisors Llcinstitution0.01%$0.00B+5.62%2024-03-31
PNC Financial Services Group, Inc.institution0.01%$0.00B+70.61%2024-03-31
Fidelity NASDAQ Composite Index Fundfund0.01%$0.00B+0.00%2024-05-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for EVGN.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.